Primary Record
Varenicline
- In stock
- 3,844 g
- Purity
- 98.1 %
- CAS
- 249296-44-4
Compound Identifiers & Properties
- CAS
- 249296-44-4
- PubChem CID
- 5310966
- SMILES
- C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23
- Canonical SMILES
- c1cnc2cc3c(cc2n1)[C@@H]1CNC[C@H]3C1
Names & Synonyms
- Varenicline
- Chantix
- Champix
- vareniclina
- Varenicline tartrate
- vareniclinum
- Vareniclene
- Varenicline Base
- Champix;
- Champix (TN)
- Chantix (TN)
- Varenicline (INN)
- 249296-44-4
- Varenicline [INN:BAN]
- W6HS99O8ZO
- RefChem:58779
- UNII-W6HS99O8ZO
- Varenicline Impurity 38
- VARENICLINE [MI]
- VARENICLINE [INN]
- VARENICLINE [HSDB]
- D0LM4A
- VARENICLINE [VANDF]
- VARENICLINE [MART.]
- US9284322, varenicline
- VARENICLINE [WHO-DD]
- CHEBI:84500
- HSDB 7591
- SCHEMBL137144
- VARENICLINE [EMA EPAR]
- CP 526555
- GTPL5459
- CHEMBL1076903
- CP-526,555
- SCHEMBL29710884
- DTXCID80197326
- DTXSID40861516
- DTXSID70891447
- N07BA03
- SYN3013
- MFCD10001497
- BDBM221048
- C13H13N3.C4H6O6
- DTXCID101030560
- ZINC1481833
- CP-526555
- EBC-47146
- NSC772250
- AKOS024457790
- AC-9008
- C13-H13-N3
- CID5310966
- NSC-772250
- compound 9a [PMID: 16171993]
- AS-16357
- BC638701
- 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine
- 2209B
- J2.192.947F
- EN300-761457
- CP-526,555-18
- 296V444
- A849621
- Q411330
- (6R,10S)-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline
- 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine
- BRD-K18855837-046-01-4
- 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline
- B0084-064059
- (1R,12S)-5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene
- 375815-87-5
- 6,10-Methano-6H-pyrazino(2,3-h)(3)benzazepine, 7,8,9,10-tetrahydro-
- 7,8,9,10-TETRAHYDRO-6H-6,10-METHANOAZEPINO(4,5-G)QUINOXALINE
- 6,7,8,9-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine
- (1R,12S)-5,8,14-triazatetracyclo(10.3.1.02,11.04,9)hexadeca-2,4,6,8,10-pentaene
- (1R,12S)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9-pentaene
- (1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
- 5,8,14-triaza-tetracyclo[10.3.1.02,11.04,9]hexadeca-2(11)-3,5,7,9-pentaene
- 5,8,14-triazatetracyclo[10.3.1.0(2,11),0(4,9)]hexadeca-2(l11),3,5,7,9-pentaene
- 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
- 7,8,9,10-Tetrahydro-6alpha,10alpha-methano-1,4,8-triaza-6H-cyclohepta[b]naphthalene
- REL-(6R,10S)-7,8,9,10-TETRAHYDRO-6H-6,10-METHANOAZEPINO[4,5-G]QUINOXALINE
- (1R,12S)-5,8,14-triazatetracyclo(10.3.1.0^(2,11).0^(4,9))hexadeca-2(11),3,5,7,9-pentaene
- 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-; 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine; CP 526555; Champix; Chantix; Varenicline
- 7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine (2R,3R)-2,3-dihydroxybutqanedioate
- 810-384-9
- QMR